Loren Gragert
National Marrow Donor Program
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Loren Gragert.
The New England Journal of Medicine | 2014
Loren Gragert; Mary Eapen; Eric Williams; John M. Freeman; Stephen Spellman; Robert L. Baitty; R.J. Hartzman; J. Douglas Rizzo; Mary M. Horowitz; Dennis L. Confer; Martin Maiers
BACKGROUND Hematopoietic stem-cell transplantation (HSCT) is a potentially lifesaving therapy for several blood cancers and other diseases. For patients without a suitable related HLA-matched donor, unrelated-donor registries of adult volunteers and banked umbilical cord-blood units, such as the Be the Match Registry operated by the National Marrow Donor Program (NMDP), provide potential sources of donors. Our goal in the present study was to measure the likelihood of finding a suitable donor in the U.S. registry. METHODS Using human HLA data from the NMDP donor and cord-blood-unit registry, we built population-based genetic models for 21 U.S. racial and ethnic groups to predict the likelihood of identifying a suitable donor (either an adult donor or a cord-blood unit) for patients in each group. The models incorporated the degree of HLA matching, adult-donor availability (i.e., ability to donate), and cord-blood-unit cell dose. RESULTS Our models indicated that most candidates for HSCT will have a suitable (HLA-matched or minimally mismatched) adult donor. However, many patients will not have an optimal adult donor--that is, a donor who is matched at high resolution at HLA-A, HLA-B, HLA-C, and HLA-DRB1. The likelihood of finding an optimal donor varies among racial and ethnic groups, with the highest probability among whites of European descent, at 75%, and the lowest probability among blacks of South or Central American descent, at 16%. Likelihoods for other groups are intermediate. Few patients will have an optimal cord-blood unit--that is, one matched at the antigen level at HLA-A and HLA-B and matched at high resolution at HLA-DRB1. However, cord-blood units mismatched at one or two HLA loci are available for almost all patients younger than 20 years of age and for more than 80% of patients 20 years of age or older, regardless of racial and ethnic background. CONCLUSIONS Most patients likely to benefit from HSCT will have a donor. Public investment in donor recruitment and cord-blood banks has expanded access to HSCT. (Funded by the Office of Naval Research, Department of the Navy, and the Health Resources and Services Administration, Department of Health and Human Services.).
Science | 2011
Laurent Abi-Rached; Matthew Jobin; Subhash Kulkarni; A.J. McWhinnie; Klara Dalva; Loren Gragert; Farbod Babrzadeh; Baback Gharizadeh; Ma Luo; Francis A. Plummer; Joshua Kimani; Mary Carrington; Derek Middleton; Raja Rajalingam; Meral Beksac; Steven G.E. Marsh; Martin Maiers; Lisbeth A. Guethlein; Sofia Tavoularis; Ann Margaret Little; Richard E. Green; Paul J. Norman; Peter Parham
Viral defense and embryo implantation mechanisms have been shaped by contributions from Neandertal and Denisovan genes. Whole genome comparisons identified introgression from archaic to modern humans. Our analysis of highly polymorphic human leukocyte antigen (HLA) class I, vital immune system components subject to strong balancing selection, shows how modern humans acquired the HLA-B*73 allele in west Asia through admixture with archaic humans called Denisovans, a likely sister group to the Neandertals. Virtual genotyping of Denisovan and Neandertal genomes identified archaic HLA haplotypes carrying functionally distinctive alleles that have introgressed into modern Eurasian and Oceanian populations. These alleles, of which several encode unique or strong ligands for natural killer cell receptors, now represent more than half the HLA alleles of modern Eurasians and also appear to have been later introduced into Africans. Thus, adaptive introgression of archaic alleles has significantly shaped modern human immune systems.
Human Immunology | 2013
Loren Gragert; Abeer Madbouly; John Freeman; Martin Maiers
We have calculated six-locus high resolution HLA A∼C∼B∼DRB3/4/5∼DRB1∼DQB1 haplotype frequencies using all Be The Match(®) Registry volunteer donors typed by DNA methods at recruitment. Mixed resolution HLA typing data was inputted to a modified expectation-maximization (EM) algorithm in the form of genotype lists generated by interpretation of primary genomic typing data to the IMGT/HLA v3.4.0 allele list. The full cohort consists of 6.59 million subjects categorized at a broad race level. Overall 25.8% of the individuals were typed at the C locus, and 5.2% typed at the DQB1 locus, while all individuals were typed for A, B, DRB1. We also present a subset of 2.90 million subjects with detailed race/ethnic information mapped to 21 population subgroups, 64.1% of which have primary DNA typing data across at least A, B, and DRB1 loci. Sample sizes at the detailed race level range from 1,242,890 for European Caucasian to 1,376 Alaskan Native or Aleut. Genetic distance measurements show high levels of HLA genetic divergence among the 21 detailed race categories, especially among the eight Asian-American populations. These haplotype frequencies will be used to improve match predictions for donor selection algorithms for hematopoietic stem cell transplantation and improve the accuracy in modeling registry match rates.
Medical Decision Making | 2008
David H. Howard; David O. Meltzer; Craig Kollman; Martin Maiers; Brent R. Logan; Loren Gragert; Michelle Setterholm; Mary M. Horowitz
Background. Transplantation with stem cells from stored umbilical cord blood units is an alternative to living unrelated bone marrow transplantation. The larger the inventory of stored cord units, the greater the likelihood that transplant candidates will match to a unit, but storing units is costly. The authors present the results of a study, commissioned by the Institute of Medicine, as part of a report on the establishment of a national cord blood bank, examining the optimal inventory level. They emphasize the unique challenges of undertaking cost-effectiveness analysis in this field and the contribution of the analysis to policy. Methods. The authors estimate the likelihood that transplant candidates will match to a living unrelated marrow donor or a cord blood unit as a function of cord blood inventory and then calculate the life-years gained for each transplant type by match level using historical data. They develop a model of the cord blood inventory level to estimate total costs as a function of the number of stored units. Results. The cost per life-year gained associated with increasing inventory from 50,000 to 100,000 units is
Tissue Antigens | 2010
William Klitz; Loren Gragert; Martin Maiers; Marcelo Fernandez-Vina; Y. Ben-Naeh; G. Benedek; Chaim Brautbar; S. Israel
44,000 to
Immunogenetics | 2012
Jill A. Hollenbach; Abeer Madbouly; Loren Gragert; Cynthia Vierra-Green; Susan Flesch; Stephen Spellman; Ann B. Begovich; Harriet Noreen; Elizabeth Trachtenberg; Thomas M. Williams; Neng Yu; Bronwen E. Shaw; Katharina Fleischhauer; Marcelo Fernandez-Vina; Martin Maiers
86,000 and from 100,000 to 150,000 units is
Biology of Blood and Marrow Transplantation | 2016
Jason Dehn; Michelle Setterholm; Kelly Buck; Jane Kempenich; Beth Beduhn; Loren Gragert; Abeer Madbouly; Stephanie Fingerson; Martin Maiers
64,000 to
Tissue Antigens | 2009
William Klitz; Loren Gragert; Martin Maiers; Bin Tu; Ana M. Lazaro; Ruyan Yang; Qihong Xu; Carly Masaberg; Jennifer Ng; Carolyn Katovich Hurley
153,000, depending on the assumption about the degree to which survival rates for cord transplants vary by match quality. Conclusion. Expanding the cord blood inventory above current levels is cost-effective by conventional standards. The analysis helped shape the Institute of Medicines report, but it is difficult to determine the extent to which the analysis influenced subsequent congressional legislation.
Tissue Antigens | 2014
Abeer Madbouly; Loren Gragert; John Freeman; Nicole Leahy; Pierre Antoine Gourraud; Jill A. Hollenbach; Malek Kamoun; Marcelo Fernandez-Vina; Martin Maiers
The Jewish diaspora can be viewed as a natural process in population dispersion and differentiation. We extend genetic studies on the Jewish diaspora to an analysis of human leukocyte antigen (HLA) haplotype distributions in the Jewish peoples, and show the value of this information for the design of Jewish marrow donor registries. HLA data from the Hadassah Bone Marrow Registry having parental country-of-origin information comprise samples of geographically discrete regions. We analyzed the HLA allele and haplotype frequencies for each national sample using population genetic and clustering methods. Population differentiation among diaspora populations was shown on the basis of HLA haplotype frequencies, including differences within the more recently diverged European groups. A method of haplotype and population clustering showed patterns of unique haplotype affinities associated with specific Jewish populations. The evidence showed that diaspora Jewish populations can be sorted into distinct clades of which the Ashkenazi are but one. Relationships among Jewish populations are interpretable in light of the historical record. We suggest that a major contributing factor to the genetic divergence between Jewish groups may have been admixture with local host populations, while, at the same time, threads of Eastern Mediterranean ancestry remain evident.
Tissue Antigens | 2013
Robert P. Milius; Steven J. Mack; Jill A. Hollenbach; Jane Pollack; Michael Heuer; Loren Gragert; Stephen Spellman; Lisbeth A. Guethlein; Elizabeth Trachtenberg; Sarah Cooley; W. Bochtler; C. R. Mueller; James Robinson; Steven G.E. Marsh; Martin Maiers
Here, we present results for DPA1 and DPB1 four-digit allele-level typing in a large (n = 5,944) sample of unrelated European American stem cell donors previously characterized for other class I and class II loci. Examination of genetic data for both chains of the DP heterodimer in the largest cohort to date, at the amino acid epitope, allele, genotype, and haplotype level, allows new insights into the functional units of selection and association for the DP heterodimer. The data in this study suggest that for the DPA1-DPB1 heterodimer, the unit of selection is the combined amino acid epitope contributed by both the DPA1 and DPB1 genes, rather than the allele, and that patterns of LD are driven primarily by dimer stability and conformation of the P1 pocket. This may help explain the differential pattern of allele frequency distribution observed for this locus relative to the other class II loci. These findings further support the notion that allele-level associations in disease and transplantation may not be the most important unit of analysis, and that they should be considered instead in the molecular context.